General Announcement::MEMBERS' VOLUNTARY LIQUIDATION OF GODO KAISHA PHOEBE
November 30, 2021 at 04:41 am EST
Share
11/30/21, 5:26 PM
Announcement details
WINDING UP / RECEIVER & MANAGER / RESTRAINING ORDER / SPECIAL ADMINISTRATOR Members' Voluntary Liquidation of Godo Kaisha Phoebe
IHH HEALTHCARE BERHAD
Type
Subject
Description
Announcement
WINDING UP / RECEIVER & MANAGER / RESTRAINING ORDER / SPECIAL ADMINISTRATOR
Members' Voluntary Liquidation of Godo Kaisha Phoebe
The Board of Directors of IHH Healthcare Berhad ("IHH") wishes to announce that HSBC Institutional Trust Services (Singapore) Limited (in its capacity as trustee of Parkway Life Real Estate Investment Trust ("PLife REIT"), an indirect 35.60%-owned subsidiary of IHH), had on 29 November 2021, terminated the Tokumei Kumiai agreement dated 11 April 2008 entered between Matsudo Investment Pte. Ltd., a wholly-owned subsidiary of PLife REIT, and Godo Kaisha Phoebe, a godo kaisha incorporated under the laws of Japan (as amended, the "TK Agreement").
In view that Godo Kaisha Phoebe no longer holds any property and consequent to the termination of the TK Agreement, Godo Kaisha Phoebe has been dissolved on 29 November 2021 after voluntary dissolution by members' resolution ("the Dissolution"). Following the Dissolution, Godo Kaisha Phoebe ceases to be a subsidiary of IHH Group.
The Dissolution will not have any effect on IHH's issued share capital and substantial shareholders' shareholdings. There shall be no material effect on the earnings, net assets or gearing of IHH for the financial year ending 31 December 2021.
None of the directors and/or major shareholders of IHH or persons connected to them, has any interest, whether direct or indirect, in the Dissolution.
IHH Healthcare Berhad published this content on 30 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 November 2021 09:40:06 UTC.
IHH Healthcare Berhad is a Malaysia-based integrated healthcare provider. The Company's segments include Hospital and Healthcare, IMU Health, Labs, PLife REIT and Others. It operates its Hospital and Healthcare segment in Singapore, Malaysia, India, Greater China, Turkey and Europe and Southeast Asia. The IMU Health segment is engaged in providing educational services. The Labs segment provides diagnostic laboratory services. The PLife REIT segment is a real estate investment trust. Through its portfolio of brands, such as Acibadem, Mount Elizabeth, Prince Court, Gleneagles, Fortis, Pantai and Parkway, the Company offers its patients comprehensive and personalized care ranging from primary to quaternary, and even ancillary services such as laboratory, diagnostics, imaging, and rehabilitation. It provides day-to-day healthcare services through outpatient treatment, routine check-ups, and vaccinations. Its secondary care comprises specialist consultation, local surgeries, and others.
IHH HEALTHCARE 
